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epidemic of dental abscesses?
Dental abscesses have increased 
most among poorer people
Thomas et al analysed aggregate data on 
drainage of abscess of alveolus of tooth from 
the hospital episode statistics (HES) website.1 I 
analysed the individual episode records for the 
same procedure (OPCS4.2 code F16.1), using 
data obtained as an extract from HES from 1 
April 1997 to 30 March 2006. Using individual 
episode data permits a greater degree  of 
resolution, particularly when combined with 
other relevant details including the relative 
deprivation of area of residence of admitted 
patients (using quintiles of the index of multiple 
deprivation2).
Worryingly these data indicate the presence 
of considerable inequalities. The figure shows 
the numbers of admissions each year stratified 
by deprivation quintile. Although the numbers 
of admissions have risen in all groups, the 
deprivation gradient is strong, with the greatest 
increase occurring among people living in the 
most deprived areas. The number of admissions 
has increased almost threefold over nine years 
for people living in the most deprived quintile 
based on the deprivation index.
Further analyses indicate that 86.3% of 
the total 8896 admissions were classified as 
being an emergency. A socioeconomic gradient 
occurs, such that people living in more affluent 
areas are less likely to have been admitted 
as an emergency (odds ratio per deprivation 
quintile=0.946 (95% confidence interval 
0.906 to 0.988, P=0.013) analysed using a 
generalised estimating equation approach to 
account for clustering). Thirty five patients were 
admitted twice over the nine year period for the 
same procedure. A stay in intensive care units 
was required in 34 episodes, and three deaths 
occurred.
My analyses, much like those of Thomas et al, 
are unable to ascribe causality, but they do paint 
a bleak picture of both a worsening situation and 
increasing socioeconomic inequalities. One of 
the most important aims of the reformation of 
NHS dentistry is to ensure the equitable provision 
of affordable dental services, as indicated in the 
subheading to Freeman’s editorial.3
David R Moles senior clinical lecturer in health services 
research, UCL Eastman Dental Institute, London WC1X 8LD 
d.moles@eastman.ucl.ac.uk
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Patients can’t see a dentist  
at short notice
The amount of dental problems general 
practitioners see seems to have risen over 
the past 10-15 years, in keeping with the 
similar decline in NHS dental work.1 We are not 
qualified to do dental work and have to preface 
our treatment with advice to this effect. The 
(empirical) experience of my patients is that 
they cannot access a dental practitioner at short 
notice for almost any problem. “Emergency” 
appointments are often available some weeks 
in advance, and the out of hours system seems 
to be difficult to access (local experience), time 
limited, and telephone based.
My overall impression is of a system that 
fails to acknowledge that what a patient calls 
an urgent problem is an urgent problem for 
the system. This seems to me to amount to 
systemic denial, and I wonder why it is that 
the government has allowed this situation 
to arise. Imagine pain or infection at another 
site—backache, pelvic inflammatory disease, 
cellulitis—to realise that a similar scenario of 
(seeming) neglect couldn’t any longer happen 
in general practice.
Hugh van’t Hoff general practitioner, May Lane Surgery, 
Dursley, Gloucestershire GL11 5AZ 
clogs@doctors.org.uk
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nice on lipid modification
nICe has overestimated 
cardiovascular risk
The National Institute for Health and Clinical 
Excellence (NICE) recommends that 
cardiovascular risk be calculated by adding 
the risks of coronary heart disease and stroke 
derived from the Framingham study.1 This is an 
elementary epidemiological error as the two risks 
are related. The effect is to overestimate risk.
The Framingham study has its limitations. UK 
data have been used to produce a UK version, 
QRISK.2 This includes much that is missing 
from Framingham, including family history and 
deprivation, as well as more accurate estimates 
of risk relating to diabetes. It represents a 
large UK population from 1995 onwards not a 
pre-1991 US population. QRISK seems to give 
a lower risk than Framingham, which, given 
the decline in cardiovascular disease over 
the years, is not surprising. The effect of using 
Framingham is also therefore to overestimate 
risk. Given that at a true risk of 20% a patient 
needs to take a statin for nearly 140-150 years 
to benefit (annual number needed to treat (NNT) 
140-150), any overestimate of risk makes that 
figure for an individual patient, whose informed 
consent is needed, look even more absurd.
Why then has the Guideline Development 
Group recommended the use of added 
Framingham based risk and rejected 
QRISK? Prevailing clinical opinion is highly 
interventionist, and good economic grounds 
numbers of admissions by year and deprivation 
quintile (top) and age at admission by deprivation 
quintile (bottom)
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exist for statins, but for the individual the 
consent is likely to be misinformed and 
probably based on the reporting of relative 
risk not absolute risk reduction. Information 
should be given to patients in ways they might 
understand like NNTs or years needed to take 
(YNTs). Lifestyle changes bring bigger gains 
across a spectrum of diseases.
Promoting statins risks encouraging a “moral 
hazard” as patients choose not to live healthier 
lives because statins will “protect” them. Such 
behaviour would substantially reduce the real 
effectiveness of statins.
Richard G Richards assistant director of public health, 
Derbyshire County Primary Care Trust, Babington Hospital, 
Belper DE56 1WH 
richard.richards@derbyshirecountypct.nhs.uk
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nICe’s simplified approach to 
lipids will not work
Although starting all patients on simvastatin 
40 mg for secondary prevention is a sound 
approach for many,1 a substantial proportion will 
not achieve the targets of less than 4 mmol/l for 
total cholesterol and 2 mmol/l for low density 
lipoprotein (LDL) cholesterol with this therapy.
A meta-analysis by Law et al in 2003 showed 
that simvastatin 40 mg achieves a reduction 
in LDL cholesterol of 37%.2 This implies that 
as initial therapy, any patient with an LDL 
measurement higher than 3.1 mmol/l would not 
be treated to target with simvastatin 40 mg. In 
the same study, simvastatin 80 mg achieved a 
42% reduction in LDL; atorvastatin 40 mg and 
rosuvastatin 20 mg achieved reductions of 49% 
and 48%, respectively.
Starting patients with an LDL of greater than 
3.1 mmol/l on simvastatin 40 mg seems to 
mean that their treatment will inevitably have 
to be escalated at a later date. This will result in 
additional clinician time, additional blood tests 
for the patient, and potentially some patients 
remaining suboptimally treated. Cheshire and 
Merseyside Cardiac Network advises starting 
atorvastatin 40 mg in all patients with a total 
cholesterol concentration higher than 6 mmol/l, 
and in practice this approach seems effective.3 
It is a shame that a similar tactic was not 
employed by NICE.
Stuart J laurie general practitioner, Long Lane Medical 
Centre, Liverpool L9 6DQ 
stuart.laurie@livgp.nhs.uk
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drug resistant tuberculosis
Service for drug resistant 
tuberculosis exists in the uK
So far the United Kingdom seems to be keeping 
clear of most of the international increase 
in drug resistant tuberculosis, in particular 
multidrug resistant tuberculosis (MDR-TB).1 2 
But how long can this be maintained?3
The problem with drug resistant tuberculosis 
is that it is still relatively uncommon but 
gradually increasing. Individual clinicians will 
have very little experience in managing cases. 
To help this situation, the MDRTB Service has 
been established at the Cardiothoracic Centre 
in Liverpool and has been operational since 1 
January 2008. The service has the support of 
the relevant professional bodies, including the 
British Thoracic Society, the British Infection 
Society, and the Health Protection Agency.
Essentially it is an electronically linked 
instant reaction expert group, who can give 
advice and direct management of cases 
across the country. It has already done so in 
some 17 cases from across the UK. By helping 
clinicians in the management of cases of 
drug resistant tuberculosis this national 
service offers our best hope in overcoming 
the increasing problem of drug resistance 
until new drugs become available. The Baltic 
states have operated a similar system for 
some years with good success in reducing 
their cases.
The second function of the service is to 
collect data on all cases of multidrug resistant 
tuberculosis identified in the UK, with a view to 
developing a consensus on the most effective 
methods of treatment. The data collection will 
also help assess outcomes of patients.
The service can be contacted by email (MDRTBservice@ctc.
nhs.uk) or by phone (0151 600 1427).
Peter D o Davies consultant physician 
Damian Cullen service coordinator, Cardiothoracic Centre, 
Liverpool L14 3PE 
mdrtbservice@ctc.nhs.uk
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paracetamol and hypertension
Time to label sodium in drug 
treatments?
A soluble tablet of 500 mg paracetamol can 
contain 388 mmol sodium, the equivalent of 
1 g salt. Here lies a more likely cause for the 
association between regular paracetamol 
use and hypertension.1 It is hard to find out 
how much salt is hidden in our patient‘s 
polypharmacy. Do medications need to label 
salt content in a similar way to food labelling? 
Would it not be possible to manufacture 
salt-free medications similar to the sugar-free 
paediatric preparations?
David R J Jarrett consultant physician, Queen Alexandra 
Hospital, Portsmouth PO6 3LY 
DavidDr.Jarrett@porthosp.nhs.uk
Competing interests: None declared.
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law on unjustified health claims
Member states must enforce 
ban on dubious products
There is law and there is the real world. In 
between lies the implementation of the law.
It is progress to now have a broad-based legal 
prohibition on all forms of misselling, including 
false health claims on foods and other products.1 
However, this impressive sounding legislation 
will have little effect on the real world unless it is 
enforced proactively and comprehensively.
Misleading health claims in advertising in 
the UK are now dealt with by the Advertising 
Standards Authority, an industry self regulatory 
body with only weak sanctions against 
transgressors. Misleading health claims on 
labels are dealt with by local authorities, who 
have such limited resources for enforcement that 
many prefer to avoid legal action altogether, lest 
they be dragged into expensive litigation, where 
the offenders have deeper pockets than the 
upholders of the law. This is a generic problem 
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opium production in afghanistan
let’s re-examine buying the 
Afghan poppies that are left
Malloch-Brown claims that the government 
has repeatedly examined the idea of legal 
poppy cultivation, such as in the 2001 report 
by Mansfield.1 2 But he ignores Mansfield’s 
2007 report, which says that evidence from 
the field shows that the growth in the opium 
poppy economy is the outcome—not the 
cause—of state and development failure in 
Afghanistan.3
Currently two strategies are being followed 
to deal with illegal opium: eradication and 
reconstruction. However, it is difficult to 
reconstruct a country on the one hand, while 
at the same time failing to establish secure 
contracts to buy up the largest sector (poppy 
production) of that country’s most important 
industry, which is agriculture. As returning 
soldiers have repeatedly pointed out, the 
battle to win hearts and minds is not helped 
by the eradication of livelihoods.
Where Malloch-Brown is right is in 
emphasising the importance of reducing 
demand for illegal drugs at home, by 
increasing and improving prevention and 
treatment services. The demand from addicts 
is fundamentally a social and health problem 
in our society.
We recognise that some provinces are 
now poppy-free and producing alternative 
crops, but we want the third policy—of buying 
up what is left—to be re-examined. If the 
Afghan poppy production could provide the 
raw product for quality controlled analgesic 
production, then for many millions of people 
around the globe pain relief may become 
feasible.
The current policy does nothing in 
humanitarian terms to tackle the enormous 
suffering through untreated pain world wide. 
The main beneficiaries at present remain the 
dealers and traffickers in illegal opium.
Ilora G Finlay professor of palliative medicine, Velindre 
Cancer Centre, Cardiff CF14 2TL 
finlayi@parliament.uk
lord Mancroft vice chairman, Parliamentary All Party Drug 
Misuse Group, House of Lords, London SW1A
Frank Field MP, founder of Poppy Relief, House of Commons, 
London SW1A
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retinal detachment
Anaesthesia for retinal 
detachment
Nitrous oxide gas (N2O) rather than volatile 
anaesthetic agents should be avoided in the 
management of retinal detachment.1 Nitrous 
oxide is highly insoluble in blood and can 
diffuse and expand into gas filled spaces 
because it is 40 times more soluble than 
nitrogen. Volatile anaesthetic agents are liquid 
at room temperature but evaporate easily for 
administration by inhalation with the use of a 
vaporiser. They require the use of a carrier gas 
such as oxygen, air, or nitrous oxide. Modern 
examples of volatile anaesthetic agents 
are sevoflurane and desflurane. A general 
anaesthetic with nitrous oxide should be avoided 
for 2-12 weeks after surgery entailing intraocular 
gas, depending on which gas has been instilled 
into the eye. Patients should be warned of the 
potentially catastrophic results of having general 
anaesthesia with nitrous oxide in this period.2
Most doctors and patients are aware that 
cataract surgery can be carried out under local 
anaesthesia, but they should also be aware 
that vitreoretinal surgery does not require 
general anaesthesia.3 This trend has been 
observed in the United States and the United 
Kingdom.4 In our institution, an increasing 
amount of vitreoretinal surgery is carried out 
with a sub-Tenon’s block because of its low 
complication rate compared with peribular 
blocks.5 Most general anaesthesia for retinal 
detachment surgery (with the exception 
of cryobuckle surgery) is done because of 
patients’ requests, compliance, or allergy to 
local anaesthetics rather than surgical need. 
General anaesthetic options available are total 
intravenous anaesthesia (used routinely in our 
institution) or a volatile anaesthetic avoiding 
nitrous oxide. The airway is usually managed 
using a flexible laryngeal mask airway unless 
an endotracheal tube is indicated. Local 
anaesthesia is a useful adjunct in providing 
postoperative analgesia.
A Hunningher specialist registrar in anaesthesia 
AHunni@blueyonder.co.uk
R Hacking consultant in anaesthesia, Moorfields Eye 
Hospital, London EC1V 2PD
Competing interests: None declared.
that hobbles all the torrent of food legislation 
that has emerged from the EU since 1992, 
including the specific new rules on nutrition and 
health claims.
It is good that European officials and 
legislators are alert to the problems of 
misrepresentation in our obese and nutritionally 
aware world. But unless the enforcement of 
their new rules is strengthened and properly 
resourced at national level, their good intentions 
will be thwarted.
The test of intention is action. Or, in plain 
English, putting your money where your mouth is. 
Unless member states are willing to enforce this 
new law, then all their protestations of concern 
about obesity and other diet-related problems 
are just more empty rhetoric—a new type of 
political false claim.
Jack T Winkler professor of nutrition policy, London 
Metropolitan University, London N7 8DB 
j.winkler@londonmet.ac.uk
Competing interests: None declared.
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additives and hyperactivity
Food dyes should be banned
Considering the numerous studies conducted 
over the past 30 years, Kemp is right in urging 
physicians to routinely encourage patients with 
hyperactivity to avoid food dyes.1 However, 
considering the dyes’ lack of health benefit and 
the risk they pose, the proper public health 
approach is for national governments to ban 
the use of all food dyes. After all, it is extremely 
difficult, firstly, for a parent to determine that 
a child is sensitive to dyes and, secondly, for 
parents to protect easily tempted children 
from tasty colourful foods that are served at 
parties; sold at stores, restaurants, and vending 
machines; and traded among friends.
The British Food Standards Agency 
deserves credit for encouraging manufacturers 
and restaurants to switch to safer, natural 
colourings. As a result of government pressure, 
Kellogg, McDonald’s, Kraft, Mars, and other 
multinational companies now market foods 
without dyes in Britain, but market the same 
foods with dyes in the United States. The US 
Food and Drug Administration maintains flatly 
that well conducted controlled studies have 
produced no evidence that food additives cause 
hyperactivity or learning disabilities in children.2
Michael Jacobson executive director, Center for Science in 
the Public Interest, Washington, DC, 20009, USA 
mjacobson@cspinet.org
Competing interests: None declared.
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campaign for real lectures
using personal experience
Like Greenhalgh,1 I have an idea of the kind 
of “real lecture” I prefer to attend. Back in the 
1990s Dr D Rowlands from Manchester Royal 
Infirmary lectured on heart failure at our district 
general hospital postgraduate medical centre. 
Instead of blinding us with science, statistics, 
and PowerPoint, his starting point was to invite 
members of the audience to volunteer their 
personal misgivings and uncertainties about 
any aspect of heart failure that they had always 
wondered about but had been too afraid to ask.
The suggestions came thick and fast, and 
he wrote each one of them down on a flip 
chart. After consultation with the audience, he 
then grouped the topics under a few clinically 
relevant subheadings so as to avoid unnecessary 
repetition. Using those headings as the basis 
of his lecture and, without the benefit of notes, 
slides, transparencies, or PowerPoint, he then 
delivered the most compelling account of heart 
failure I have ever heard, using a synthesis of 
references to the medical literature and his own 
extensive personal experience so as to reach out 
to each and every member of that audience. That 
style of delivery, like an inspirational speech, has 
enduring value.
oscar M Jolobe retired geriatrician, Manchester Medical 
Society, c/o John Rylands University Library,  
Manchester M13 9PP oscarjolobe@yahoo.co.uk
Competing interests: None declared.
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Chalk and blackboard
The best lecture I had at medical school was 
given by a retired professor of respiratory 
medicine at Charing Cross, Stephen Semple, a 
good 10 years ago. He shuffled down to the front 
of the lecture hall, took a (semi-) disgusted look 
at the overhead projector (remember those?) and 
cranked the antiquated blackboards into life. 
He then spoke, without notes, for 90 minutes 
on respiratory physiology, only using a crumbly 
piece of yellow chalk to illustrate his points. 
The diagrams, both cellular and those of gross 
anatomy, were beautifully clear, and I remember 
the principles he taught to this day.
He demonstrated that the key to being a good 
teacher, and a good lecturer, is knowing your 
stuff—the rest just falls into place.1
Andrew J Heeps ST2, obstetrics and gynaecology, Chelsea 
and Westminster Hospital, London SW10 9NH 
andy.heeps@googlemail.com
Competing interests: None declared.
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Beyond bullet points
Of interest may be a book and supporting 
website called Beyond Bullet Points by Cliff 
Atkinson (www.beyondbullets.com/).1 He 
promotes a no-bullet-point approach to 
presentations and, further, suggests a filmscript 
type approach to the construction of the 
message or story to be delivered.2
This style is more time consuming to 
put together, and the greatest hurdle I’ve 
had to face is not having the bullet points 
as a reminder of what I have to say. I have, 
however, had much better feedback from 
these presentations than from my “standard” 
PowerPoint slide sets.
Paul Davies pharmacist, Mental Health Partnerships NHS 
Greater Glasgow and Clyde, Glasgow G3 8YZ 
paul.davies2@ggc.scot.nhs.uk
Competing interests: None declared.
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Take the zen approach
Another excellent resource for engaging, image-
based presentations1 is the Presentation Zen 
blog (www.presentationzen.com) and associated 
book. As well as denigrating the use of bullet 
pointed, text heavy slides (which seem often 
to be designed with automatically generated 
handouts in mind, rather than as visual aids), its 
author, Garr Reynolds, urges presenters to focus 
on the story that their presentation is trying to 
tell, rather than getting caught up in the minutiae 
of font sizes and sound effects.
Ben Braithwaite general practitioner, Richford Gate Medical 
Practice, London W6 7HY 
flaneurben@gmail.com
Competing interests: None declared.
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the world is round
Salute to the stethoscope
Is Spence really unaware of the pioneering 
work of the postwar generation of general 
practitioners who re-established the 
stethoscope as a valuable aid not to 
auscultation but to meditation?1 I can still 
recall the thrill of discovering that if I placed 
the business end of my stethoscope over an 
inert portion of a patient and used the other 
ends to plug my ears, I could create the perfect 
ambience for contemplating not just trivial 
problems such as “What is the matter with 
this patient?” but more serious ones such as 
“What is his or her name?”, or “What crisp, 
reassuring, non-discussion provoking phrase 
will get me out of here in time to watch the 
football on television?”
The beauty of this clinical manoeuvre is that 
the very act that enables you to struggle with your 
own problems gives your patients the impression 
you are thinking deeply about theirs. As a result, 
you can make decisions free from the pressure of 
time. The longer you take, the more your patient 
is impressed by your thoroughness.
Sophisticates improve this empowering 
quality by bunging the earpieces with cotton 
wool to eliminate distracting sounds that 
may intrude if they inadvertently place the 
instrument over the heart or other noisy organ. 
Sound proofed stethoscopes are particularly 
useful for dealing with talkative patients whom 
a doctor can halt in full flow by applying the 
instrument to their chests and telling them to 
breathe deeply.
Over the years, doctors have found many 
uses for the stethoscope—as a tourniquet, a 
paperweight, a hook for retrieving hats that 
have fallen behind chests of drawers, and an 
effective binder for boxes with loose lids. I knew 
a senior doctor who used an old stethoscope 
to keep his trousers up and a junior one who, 
when facing a personal credit crunch, would use 
his stethoscope to siphon petrol from cars left 
overnight in the hospital car park.
Michael o’Donnell former general practitioner; journeyman 
writer and broadcaster, Loxhill GU8 4BD 
mod@doctors.org.uk
Competing interests: None declared.
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